Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Gartlehner

Showing results (81-90 of 281) with videos related to

Pageof 29
Sort By:
Health Information and Libraries Journal|September 18, 2008
Strategies in assessing the need for updating evidence-based guidelines for six clinical topics: an exploration of two search methodologiesChristiane E Voisin, Claire de la Varre, Lynn Whitener, et al.
Lancet (London, England)|May 26, 2009
Ranking antidepressantsGerald Gartlehner, Bradley N Gaynes, Richard A Hansen, et al.
Drugs & Aging|February 23, 2007
Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysisRichard A Hansen, Gerald Gartlehner, Kathleen N Lohr, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|March 4, 2020
Gero Langer, Gerald Gartlehner, Lukas Schwingshackl, et al.
BMJ (Clinical Research Ed.)|February 12, 2016
Authors' reply to Gøtzsche and HamiltonHalle R Amick, Gerald Gartlehner, Bradley N Gaynes, et al.
Journal of Clinical Epidemiology|December 9, 2014
Grades for quality of evidence were associated with distinct likelihoods that treatment effects will remain stableGerald Gartlehner, Isolde Sommer, Tammeka Swinson Evans, et al.
Research Synthesis Methods|April 11, 2022
Crowdsourcing the identification of studies for COVID-19-related Cochrane Rapid ReviewsAnna Noel-Storr, Gerald Gartlehner, Gordon Dooley, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|September 1, 2020
Birgit Teufer, Barbara Nußbaumer-Streit, Lukas Schwingshackl, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Second-generation antidepressants for seasonal affective disorderKylie Thaler, Marlene Delivuk, Andrea Chapman, et al.
Journal of Affective Disorders|December 4, 2017
Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysisGernot Wagner, Marie-Therese Schultes, Viktoria Titscher, et al.
Pageof 29

Showing results (81-90 of 281) with videos related to

Sort By:
Pageof 29
Health Information and Libraries Journal|September 18, 2008
Strategies in assessing the need for updating evidence-based guidelines for six clinical topics: an exploration of two search methodologiesChristiane E Voisin, Claire de la Varre, Lynn Whitener, et al.
Lancet (London, England)|May 26, 2009
Ranking antidepressantsGerald Gartlehner, Bradley N Gaynes, Richard A Hansen, et al.
Drugs & Aging|February 23, 2007
Functional outcomes of drug treatment in Alzheimer's disease: A systematic review and meta-analysisRichard A Hansen, Gerald Gartlehner, Kathleen N Lohr, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|March 4, 2020
Gero Langer, Gerald Gartlehner, Lukas Schwingshackl, et al.
BMJ (Clinical Research Ed.)|February 12, 2016
Authors' reply to Gøtzsche and HamiltonHalle R Amick, Gerald Gartlehner, Bradley N Gaynes, et al.
Journal of Clinical Epidemiology|December 9, 2014
Grades for quality of evidence were associated with distinct likelihoods that treatment effects will remain stableGerald Gartlehner, Isolde Sommer, Tammeka Swinson Evans, et al.
Research Synthesis Methods|April 11, 2022
Crowdsourcing the identification of studies for COVID-19-related Cochrane Rapid ReviewsAnna Noel-Storr, Gerald Gartlehner, Gordon Dooley, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|September 1, 2020
Birgit Teufer, Barbara Nußbaumer-Streit, Lukas Schwingshackl, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Second-generation antidepressants for seasonal affective disorderKylie Thaler, Marlene Delivuk, Andrea Chapman, et al.
Journal of Affective Disorders|December 4, 2017
Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysisGernot Wagner, Marie-Therese Schultes, Viktoria Titscher, et al.
Pageof 29